无特定分子特征子宫内膜癌中雌激素受体表达与雌激素信号传导的预后意义:一项全面的分子与病理分析
研究纳入1835例拷贝数低(CNL)/无特定分子特征(NSMP)子宫内膜癌,随机选取100例以免疫组化评估ER与PTEN表达。ER阳性率85%,ER缺失与更差无进展生存(HR 3.75)和总生存(HR 6)显著相关;PTEN缺失率59%但与生存无关。多因素分析中高级别组织学、ER缺失及无任何雌激素信号来源为总生存不良的显著预后因素。
要点
- CNL/NSMP子宫内膜癌中ER阳性率为85%,ER缺失与更差的无进展生存和总生存显著相关。
- PTEN表达缺失见于59%的CNL/NSMP子宫内膜癌,但未显示与生存结局相关。
- 多因素分析显示高级别组织学、ER缺失和无雌激素信号来源是总生存不良的显著预后因素。
核心结论
- 在CNL/NSMP子宫内膜癌中,ER阳性与更有利的生存结局相关,支持基于ER免疫组化将患者分为两个不同的预后亚组。
研究设计与样本
- 研究共识别1835例接受410-468个癌症相关基因临床测序的CNL/NSMP子宫内膜癌,随机选取其中100例通过免疫组化评估ER和PTEN表达。
- 记录肿瘤组织学、卵巢体积、绝经状态、体重指数、外源性雌激素来源及ESR1热点突变等临床病理资料,采用Cox回归模型评估预后价值。
主要发现
- CNL/NSMP子宫内膜癌中ER阳性率为85%,ER表达缺失与不良无进展生存显著相关(HR 3.75;95%CI 1.78-7.9),与不良总生存显著相关(HR 6;95%CI 2.39-15.1)。
- PTEN表达缺失见于59%的CNL/NSMP子宫内膜癌,但未与生存结局相关。
- 多因素分析显示高级别组织学(HR 6.75;95%CI 2.5-17.9)、ER表达缺失(HR 3.46;95%CI 1.2-9.7)及无任何雌激素信号来源(HR 3.87;95%CI 1.4-10.7)为总生存不良的显著预后因素。
临床怎么用
- 原文结论支持基于ER免疫组化将CNL/NSMP子宫内膜癌患者分为两个不同的预后亚组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Copy number-low (CNL) endometrial cancer (EC), also known as no specific molecular profile (NSMP), is the most heterogeneous molecular subtype. In this study, we evaluated the prognostic significance of estrogen receptor (ER) and PTEN expression in primary untreated CNL/NSMP ECs across all histologic subtypes to further refine risk stratification within this heterogeneous group. METHODS: We identified a total of 1835 CNL/NSMP ECs that underwent clinical sequencing of 410-468 cancer-related genes. Of these, we randomly selected 100 CNL/NSMP ECs and evaluated ER and PTEN expression by immunohistochemistry. We recorded clinicopathological data regarding tumor histology and estrogen signaling sources, including ovarian volume, menopausal status, body mass index, exogenous sources of estrogen, and hotspot mutations in ESR1. We used Cox regression models to evaluate the prognostic value of these variables. RESULTS: We observed ER positivity in 85 % of CNL/NSMP ECs, with absence of ER expression significantly associated with adverse progression-free (HR, 3.75; 95 % CI, 1.78-7.9) and overall survival (HR, 6; 95 % CI, 2.39-15.1). We observed PTEN loss of expression in 59 % of CNL/NSMP ECs, but it was not associated with survival outcomes. Multivariate analysis identified high-grade histology (HR, 6.75; 95 % CI, 2.5-17.9), lack of ER expression (HR, 3.46; 95 % CI, 1.2-9.7), and absence of any estrogen signaling sources (HR, 3.87; 95 % CI, 1.4-10.7) as significant prognostic factors for poor overall survival. CONCLUSION: ER positivity is associated with more favorable survival outcomes in CNL/NSMP EC. These data support dividing patients with CNL/NSMP EC into two distinct prognostic subgroups based on ER immunohistochemistry.
引用
- Lam C, Zhou Q, Aghajanian C, et al. Prognostic significance of estrogen receptor expression and estrogen signaling in endometrial carcinomas of no specific molecular profile: A comprehensive molecular and pathologic analysis. Gynecol Oncol. 2025. PMID: 40414144. doi:10.1016/j.ygyno.2025.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。